Article

New Issue Alert: CURE Spring

We've got a sneak peek at what’s inside CURE®'s spring issue.

Does cannabis have a positive effect on patients with cancer? Although researchers are still conducting studies to gain further evidence, its popularity is driving its legalization for therapeutic use. Our cover story, Flower Power, covers all the angles.

Next, patients with head and neck cancer are Keeping the Options Open. Learn about the less toxic treatment choices that are moving to be used as initial therapy for patients ­— and, hopefully, improving their quality of life.

And, at the age of 21, one woman was told she had the BRCA1 gene mutation, which meant she had a 55 to 85 percent lifetime risk of developing breast cancer. Years later, and after undergoing a double, prophylactic mastectomy, she learned she was misdiagnosed. Her story, plus how she’s Making Lemonade from life’s lemons.

To read these stories and more, visit curetoday.com/publications and click on the latest CURE® cover. Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

And, as always, thanks for reading.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content